A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore Tolerability, Safety and Efficacy of the H-Coil Deep TMS
15 medical centers in the USA, Canada, Europe and Israel
16 September, 2009
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep TMS in Major Depression
A multicenter clinical trial for the assessment of the efficacy and safety of deep brain rTMS in subjects suffering from major depression disorder (MDD) has begun in 15 medical centers in the USA, Canada, Europe and Israel. Enrollment of patients has begun in six sites.
Clinical Trial: Smoking cessation in chronic obstructive pulmonary disease - Safety and Feasibility
Be'er Ya'akov Mental Health Center, Israel
1 July, 2009
A clinical trial for the assessment of the efficacy of Deep TMS in inducing smoking cessation in chronic obstructive pulmonary disease patients, has begun in July 2009 at the Mental Health Center in Be'er Ya'akov, Israel.
A clinical trial using Brainsway Deep TMS device for the treatment of Alzheimer's disease, has begun in April 2009, at the Ichilov Medical Center, Tel-Aviv, Israel.
40 patients are expected to take part in the trial
Clinical Trial: Schizophrenia - Double Blind Placebo Control
Shalvata Hospital, Hod Hasharon, Israel
9 March, 2009
Brainsway Ltd. (the "Company") announces that further to the approval of the Helsinki Committee of the Shalvata Hospital, the Company received the Ministry of Health's approval for the performance of an additional trial of a broader scope, that will be double blinded, utilizing the Company's Deep TMS device for the treatment of negative symptoms in 45 subjects suffering from schizophrenia
Hadassah Ein Kerem Medical Center, Jerusalem, Israel
26 January, 2009
A clinical trial using Brainsway Deep TMS device for the treatment of post-traumatic stress disorder, has begun in May 2007, at the Hadassah Ein Kerem Medical Center, Jerusalem, Israel.
Clinical Trial: Bi-Polar Disorder - Double Blind Placebo Control
Shalvata Hospital, Hod Hasharon, Israel
13 January, 2009
Brainsway Ltd. (the "Company") announces that further to the approval of the Helsinki Committee of the Shalvata Hospital, the Company received the Ministry of Health's approval for the performance of an additional trial of a broader scope, that will be double blinded, utilizing the Company's Deep TMS device with respect to 50 subjects suffering from Bipolar Depression.
Shalvata Mental Health Center, Hod-Hasharon, Israel.
14 February, 2008
A clinical trial using the Deep TMS device for a maintenance treatment in depression patients, began in June 2008 at the Shalvata Medical Centre, Israel. The trial is intended to include 20 medication-resistant major depression patients who previously participated in a trial for the treatment of major depression at the Shalvata Hospital whose results were reported in the Company's immediate report dated 14 February 2008.
Clinical Trial: Autism/Asperger Syndrome - Agreement to Perform
'Alfred' Medical Centre in Melbourne, Australia
12 February, 2008
Brainsway Ltd. (the "Company") is pleased to announce that on this day, February 12th 2008, it has entered into an agreement with the Alfred Psychiatry Research Centre in Melbourne, Australia (the "Alfred Centre") to perform human clinical trials.
A clinical trial using Brainsway Deep TMS device for the treatment of Parkinson’s disease, has begun in May 2007, at the Sheba Medical Center at Tel Hashomer, Israel.
40 patients are expected to take part in the trial
Clinical Trial: Interim Results for Blepharospasm (Uncontrolled Blinking)
National Institute of Health (NIH) ,Bethesda, Meryland, USA
17 January, 2008
Interim results reported by the researchers: The treatment has alleviated the patients' symptoms, and they have identified an improvement of the blink reflex recovery curve...
Home
Site Map
Contact Us
Send to a friend
Print page